Chemical industry – Page 14
-
BusinessGilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments
-
OpinionGiving companies room to grow
Can shopping centres and offices become urban lab spaces for innovative companies to grow and scale-up?
-
BusinessOut of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
-
BusinessThe hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
-
BusinessThe problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
-
OpinionPolymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
NewsFears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad
-
BusinessAcceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
-
OpinionThe value of good software extends beyond its cost
Whether third-party or built in-house, thoughtful design and implementation can improve workflows and make science more inclusive
-
ResearchImproving propylene synthesis using light-activated catalysis could cut emissions
Single-atom photocatalyst makes propylene at milder temperatures
-
Business29 dead in explosions at two illegal fireworks factories in India
Incidents in Gujarat and West Bengal highlight minimal oversight of hazardous industry
-
BusinessBioLab fined for fire and chemical plume at US plant
‘Improperly stored’ pool chemicals reacted with water to release chlorine
-
BusinessGovernment reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
-
BusinessEpigenetic editors enter clinical trials
New wave of precision medicines amplify or silence genes, without altering genetic code
-
FeatureMaking genetically engineered food palatable
The next generation of genetically altered food is forging ahead, aiming to be attractive to consumers rather than producers. Katrina Megget finds out whether Crispr means crisper salads
-
BusinessTrump’s new tariffs threaten the chemicals sector
Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries
-
OpinionTrump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard
-
BusinessJ&J’s third talc bankruptcy settlement attempt denied
Company says it will return to courts to fight talc cancer claims
-
BusinessUS regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
-
